BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsubota, K.
Right arrow Articles by Shimmura, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsubota, K.
Right arrow Articles by Shimmura, S.
Topic Collections
Right arrowRelevant Article
Br J Ophthalmol 1999;83:390-395 ( April )

Treatment of dry eye by autologous serum application in Sjögren's syndrome

Kazuo Tsubota,a b c Eiki Goto,a b c Hiromi Fujita,a c Masafumi Ono,a d Hiroko Inoue,a Ichiro Saito,e Shigeto Shimmuraa b c

a Department of Ophthalmology, Tokyo Dental College, Chiba, Japan, b Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan, c Oral Research Center, Tokyo Dental College, Chiba, Japan, d Department of Ophthalmology, Tokai University School of Medicine, Kanagawa, Japan, e Department of Pathology, Tokushima University School of Dentistry, Tokushima, Japan

Correspondence to: Kazuo Tsubota, MD, Department of Ophthalmology, Tokyo Dental College, 11-13 Sugano 5 Chome, Ichikawa-shi, Chiba, Japan 272-8513.

Accepted for publication 26 August 1998

AIM---To evaluate the efficacy of autologous serum application for the treatment of dry eye in Sjögren's syndrome.
METHODS---The stability of essential components (EGF, vitamin A, and TGF-beta ) in preserved serum were examined following preservation at 4°C and -20°C. In a primary clinical trial, 12 patients with Sjögren's syndrome were treated with autologous serum (diluted to 20% with sterile saline) for 4 weeks, and vital staining of the ocular surface was compared before and after treatment. The effects of serum on mucin (MUC-1) expression were observed in cultured conjunctival epithelial cells in vitro.
RESULTS---EGF, vitamin A, and TGF-beta were well preserved for up to 1 month in the refrigerator at 4°C and up to 3 months in the freezer at -20°C. Rose bengal and fluorescein scores improved significantly from the initial scores of 5.3 and 5.6 to 1.7 and 2.5 after 4 weeks, respectively. The additive effect of human serum for cultured conjunctival epithelial cells showed significant MUC-1 upregulation on the cell surface.
CONCLUSION---Autologous serum application is a safe and efficient way to provide essential components to the ocular surface in the treatment of dry eye associated with Sjögren's syndrome.

Keywords: autologous serum; Sjögren's syndrome; tears ocular surface


© 1999 by British Journal of Ophthalmology

Relevant Article

Much more than water
J DANIEL NELSON
Br. J. Ophthalmol. 1999 83: 384-385. [Extract] [Full Text]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd.